Managing DME When Anti-VEGF Response Is Limited

• by Baruch D. Kuppermann, MD, PhD, Michael A. Singer, MD

• March 1, 2026

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• April 29, 2026

• 4 min

Retinal Layer Reflectivity and Thickness as OCT Biomarkers for Diagnosis and Imaging-Based Stratification Relative to the 4.5-Hour Window in Acute Central Retinal Artery Occlusion

• by Walter, Alessandra , Wenzel, Daniel A., Poli, Sven , Druchkiv, Vasyl , Beuse, Ansgar , Schultheiss, Maximilian , Spitzer, Martin , Bartz-Schmidt, Karl Ulrich, Grohmann, Carsten

• April 6, 2026

The Retina: A Window on Neurodegeneration

New evidence links Chlamydia pneumoniae to retinal inflammation patterns associated with neurodegeneration

• March 9, 2026

• 7 min